168 related articles for article (PubMed ID: 2971411)
1. Significance of atrial natriuretic factor in chronic heart failure.
McMurray J; Struthers AD
Br J Hosp Med; 1988 Jul; 40(1):55-7. PubMed ID: 2971411
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic application of atrial natriuretic peptide for congestive heart failure].
Harada M; Nakao K
Nihon Rinsho; 2007 May; 65 Suppl 5():115-9. PubMed ID: 17571375
[No Abstract] [Full Text] [Related]
3. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
Stoupakis G; Klapholz M
Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic application of ANP: past and future].
Saito Y
Nihon Rinsho; 2004 Sep; 62 Suppl 9():139-46. PubMed ID: 15506358
[No Abstract] [Full Text] [Related]
5. [Auricular natriuretic factor].
Gamba G; Peña JC
Rev Invest Clin; 1987; 39(1):81-92. PubMed ID: 2955494
[No Abstract] [Full Text] [Related]
6. Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure.
Chee KH; Amudha K; Hussain NA; Haizal HK; Choy AM; Lang CC
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):140-8. PubMed ID: 14608517
[TBL] [Abstract][Full Text] [Related]
7. [Atrial natriuretic peptide for therapy of heart failure].
Takeda N
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):270-5. PubMed ID: 15768591
[No Abstract] [Full Text] [Related]
8. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
Fontana F; Guardigli G; Cappelli M; Bernardi P
G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experiences with atrial natriuretic factor].
Brunner HR; Biollaz J; Waeber B; Nussberger J
Schweiz Med Wochenschr; 1987 Dec; 117(49):1937-40. PubMed ID: 2962282
[TBL] [Abstract][Full Text] [Related]
10. [Human atrial natriuretic peptide: a secretory product of the heart and its significance for physiology and clinical practice].
Vierhapper H; Waldhäusl W
Wien Klin Wochenschr; 1987 Mar; 99(5):133-8. PubMed ID: 2953110
[TBL] [Abstract][Full Text] [Related]
11. [Is there a clinical indication for the determination of atrial natriuretic peptide?].
Reiss U; Stimpel M
Schweiz Rundsch Med Prax; 1993 Jul; 82(27-28):755-8. PubMed ID: 8346382
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
13. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
[TBL] [Abstract][Full Text] [Related]
14. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
[TBL] [Abstract][Full Text] [Related]
15. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
16. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
[TBL] [Abstract][Full Text] [Related]
17. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
18. Neutral endopeptidase 24.11: a modulator of natriuretic peptides.
Margulies KB; Burnett JC
Semin Nephrol; 1993 Jan; 13(1):71-7. PubMed ID: 8434188
[No Abstract] [Full Text] [Related]
19. [Atrial natriuretic factor in cardiovascular diseases].
Nakamura M; Arakawa N; Hiramori K
Kokyu To Junkan; 1991 Oct; 39(10):971-8. PubMed ID: 1836068
[No Abstract] [Full Text] [Related]
20. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
